# Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule

> **NCT00572000** · NA · UNKNOWN · sponsor: **National Institute for Control of Vaccine and Biologicals** · enrollment: 222 (estimated)

## Conditions studied

- Human Papillomavirus (HPV) Vaccine

## Interventions

- **BIOLOGICAL:** HPV-16/18 L1 VLP AS04 vaccine

## Key facts

- **NCT ID:** NCT00572000
- **Lead sponsor:** National Institute for Control of Vaccine and Biologicals
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 222 (ESTIMATED)
- **Last updated:** 2007-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572000, "Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Healthy Vietnamese Women According to a 0, 1, 6 Month Schedule". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00572000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*